BioSpace News Archive

ACTO , the creator of the innovative Omnichannel Education Platform for Life Sciences, today announced it won a coveted Brandon Hall Group Gold award for excellence in Best Advance in Learning Management.

Rapid Dose Therapeutics Corp. is pleased to announce a significant addition to the Company’s leadership team with the appointment of Rodney Butt as the lead consultant overseeing the development of the Company’s COVID-19 vaccine delivery platform.

Taysha Gene Therapies, Inc. today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI) in accordance with the annual reconstitution of the index, effective prior to the U.S. market open on Monday, December 20, 2021.

The first targeted C3 therapy approved in the EU Approval based on results from head-to-head PEGASUS phase 3 study where Aspaveli demonstrated superiority to eculizumab in improving haemoglobin levels 1.

9 Meters Biopharma, Inc. today announced the company has awarded an unrestricted educational grant to Carol Rees Parrish, M.S., RDN, a GI Nutrition Support Specialist to support a new educational website: SBSCurbside.

Remix Therapeutics, a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the underlying drivers of disease, announced the appointment of Zaven Kaprielian, Ph.D., as Chief Scientific Officer.

Pyxis Oncology, Inc., a preclinical oncology company focused on developing next-generation therapeutics for difficult to treat cancers, announced that the company will be added to the Russell 2000® Index, effective after the U.S. market opens on December 20, 2021, according to the preliminary list of IPO additions to the Russell indexes.

The SanBio Group today announced it is one of the founding member organizations of the National TBI Registry Coalition (NTRC) in the United States.

MGI Tech Co., Ltd. is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies.

XPhyto Therapeutics Corp. is pleased to provide an update on the development of its fast-dissolving CBD oral strips.